Related Experiment Video
Updated: May 24, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the
Daichi Shimbo1, Jonathan D Newman, Joseph E Schwartz
1Department of Medicine, Columbia University Medical Center, New York, New York, USA. ds2231@columbia.edu
Insights
Masked hypertension and prehypertension significantly overlap and are linked to increased cardiovascular risk. Ambulatory blood pressure monitoring may not be necessary for individuals with optimal clinic blood pressure.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Diagnostics
Background:
- Masked hypertension (MHT) and prehypertension (PHT) increase cardiovascular disease (CVD) risk compared to normotension.
- Understanding the overlap between MHT and PHT is crucial for assessing CVD risk.
- Left ventricular mass index (LVMI) is a key indicator of cardiovascular end-organ damage.
Purpose of the Study:
- To investigate the diagnostic overlap between masked hypertension and prehypertension.
- To examine the relationship between MHT, PHT, and left ventricular mass index (LVMI).
Main Methods:
- 813 participants without treated hypertension underwent clinic blood pressure (CBP) and 24-hour ambulatory blood pressure (ABP) monitoring.
- Left ventricular mass index (LVMI) was assessed via echocardiography in 784 participants.
- Data analysis adjusted for multiple cardiovascular risk factors.
Main Results:
- A significant overlap was observed: 83.8% of MHT participants also had PHT, and 34.1% of PHT participants had MHT.
- MHT was rare (3.9%) in individuals with optimal CBP (<120/80 mm Hg).
- Elevated LVMI was associated with both PHT without MHT and PHT with MHT, compared to optimal CBP with MHT.
Conclusions:
- Substantial diagnostic overlap exists between masked hypertension and prehypertension in a community sample.
- Ambulatory blood pressure monitoring may not be clinically indicated for individuals with optimal clinic blood pressure readings.
- Further research is needed to refine diagnostic strategies for hypertension subtypes.
Background:
Masked hypertension (MHT) and prehypertension (PHT) are both associated with an increase in cardiovascular disease (CVD) risk, relative to sustained normotension. This study examined the diagnostic overlap between MHT and PHT, and their interrelationships with left ventricular (LV) mass index (LVMI), a marker of cardiovascular end-organ damage.
Methods:
A research nurse performed three manual clinic blood pressure (CBP) measurements on three occasions over a 3-week period (total of nine readings, which were averaged) in 813 participants without treated hypertension from the Masked Hypertension Study, an ongoing worksite-based, population study. Twenty-four-hour ambulatory blood pressure (ABP) was assessed by using a SpaceLabs 90207 monitor. LVMI was determined by echocardiography in 784 (96.4%) participants.
Results:
Of the 813 participants, 769 (94.6%) had normal CBP levels (<140/90 mm Hg). One hundred and seventeen (15.2%) participants with normal CBP had MHT (normal CBP and mean awake ABP ≥135/85 mm Hg) and 287 (37.3%) had PHT (mean CBP 120-139/80-89 mm Hg). 83.8% of MHT participants had PHT and 34.1% of PHT participants had MHT. MHT was infrequent (3.9%) when CBP was optimal (<120/80 mm Hg). After adjusting for age, gender, body mass index (BMI), race/ethnicity, history of high cholesterol, history of diabetes, current smoking, family history of hypertension, and physical activity, compared with optimal CBP with MHT participants, LVMI was significantly greater in PHT without MHT participants and in PHT with MHT participants.
Conclusions:
In this community sample, there was substantial diagnostic overlap between MHT and PHT. The diagnosis of MHT using an ABP monitor may not be warranted for individuals with optimal CBP.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Hypertension I: Introduction
Mitral Regurgitation I: Introduction
Measurement of Blood Pressure
